Target intelligence / Profile preview

ACTR3 antisense RNA 1 (ACTR3-AS1)

Target
ACTR3-AS1
Molecular classification
Other, Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

ACTR3 antisense RNA 1 (ACTR3-AS1), also known as AC104653.1, is a long non-coding RNA (lncRNA) gene classified as an antisense RNA transcript[3]. Antisense lncRNAs like ACTR3-AS1 are transcribed from the DNA strand opposite a protein-coding gene—in this case, ACTR3—and often regulate the expression of their sense partner gene through various mechanisms such as recruiting chromatin modifiers, modulating transcript stability, or influencing methylation patterns[1][2]. These molecules can impact gene expression post-transcriptionally in the cytoplasm or influence epigenetic states within the nucleus[1][2]. While the general class of antisense lncRNAs is recognized for diverse roles in cancer progression and gene regulation, there is limited direct evidence specifically linking ACTR3-AS1 to a well-defined therapeutic mechanism, disease biomarker status, or drug interactions[1][3].

Other names
AC104653.1ACTR3-AS1
02

Biological functions

Gene expression regulationEpigenetic regulationPost-transcriptional regulationRNA stability
03

Disease associations

Cancer (implicated broadly in cancer biology and possibly specific subtypes, but not as a direct druggable target)

Beyond the preview

Go deeper on ACTR3 antisense RNA 1 (ACTR3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACTR3 antisense RNA 1 (ACTR3-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call